2013 ACC/AHA Guideline: A Guideline for the Population—Without Evidence from the Population Merle MyersonRobert S. Rosenson EDITORIAL 08 March 2014 Pages: 203 - 204
The Effects of Anti-Diabetic Drugs on LDL Subclasses: Any Role for Colesevelam? Manfredi RizzoDimitri P. MikhailidisKhalid Al-Rasadi EDITORIAL 28 May 2014 Pages: 205 - 207
Healthy Aging in Finland: Patients Adhere Well to Chronic Statin Therapy and Their Doctors to the Guidelines Robert H. Vander SticheleYoleen Van Camp EDITORIAL 23 May 2014 Pages: 209 - 210
Granulocyte-Colony Stimulating Factor Reduces Cardiomyocyte Apoptosis and Ameliorates Diastolic Dysfunction in Otsuka Long-Evans Tokushima Fatty Rats Jeong Hun ShinYoung-Hyo LimKyung-Soo Kim ORIGINAL ARTICLE 27 April 2014 Pages: 211 - 220
Diverse Regulation of Cardiac Expression of Relaxin Receptor by α1- and β1-Adrenoceptors Xiao-Lei MooreYidan SuXiao-Jun Du ORIGINAL ARTICLE 23 May 2014 Pages: 221 - 228
Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus Robert S. RosensonScott P. RigbyHubert S. Chou ORIGINAL ARTICLE Open access 08 April 2014 Pages: 229 - 236
Galectin-3: A Modifiable Risk Factor in Heart Failure Rudolf A. de BoerA. Rogier van der VeldeAlan Maisel REVIEW ARTICLE 02 May 2014 Pages: 237 - 246
Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation A. JalotaT. M. ScarabelliJ. Halperin REVIEW ARTICLE 20 May 2014 Pages: 247 - 262
Older Statin Initiators in Finland—Cardiovascular Risk Profiles and Persistence of Use Eveliina UpmeierMaarit Jaana KorhonenRisto Huupponen ORIGINAL ARTICLE 02 April 2014 Pages: 263 - 272
Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: Randomised Comparison of Bivalirudin Versus Unfractionated Heparin in Patients at High Risk of Bleeding Undergoing Elective Coronary Stenting Throught The Femoral Approach. Rationale and Design Carlo BriguoriGabriella ViscontiBruno Ricciarelli ORIGINAL ARTICLE 01 May 2014 Pages: 273 - 279
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies John J. P. KasteleinJennifer G. RobinsonMarie T. Baccara-Dinet ORIGINAL ARTICLE Open access 20 May 2014 Pages: 281 - 289
Hypertension, Platelets, and Inflammatory Responses L. H. Opie LETTER TO THE EDITOR 31 January 2014 Pages: 291 - 292